Working… Menu

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03302403
Recruitment Status : Active, not recruiting
First Posted : October 5, 2017
Last Update Posted : October 8, 2020
CARsgen Therapeutics Co., Ltd.
Information provided by (Responsible Party):
Kang YU, First Affiliated Hospital of Wenzhou Medical University

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 12, 2020
Estimated Study Completion Date : December 12, 2023